While outpatient ethics training is relatively scant, many primary care clinicians encounter challenging situations in clinic that raise ethical considerations—and the pandemic has brought several important ethical questions and dilemmas to the forefront. This case-based discussion will review strategies for managing these moral dilemmas in the age of COVID-19.
Asthma & chronic obstructive pulmonary disease (COPD) can have overlapping symptoms, but they are characterized by different pathogenic mechanisms and different responses to anti-inflammatory therapies. Dozens of medications and interventions have been approved and prescribed to combat these diseases, and treatments strategies have been developed that depend largely on severity of symptoms. But how should we approach these patients? What’s new in asthma and COPD? This case-based presentation will help you review what you need to know about asthma and COPD in 2020.
Differences in the African American Diet and Strategies to Impact Choices: Patient-Centered Clinical Care of African Americans
Episode 8: Bridging the Gap: Conversations with Dr. Hall
You may be aware of dietary differences in the African American community, but you may not know the full story. Historical, cultural, and socioeconomic factors play a significant role in the food choices African Americans often make. Before you tell your next African American patient to “eat better,” you need to watch this presentation to understand the research-based differences in the African American diet and how it has evolved. You will also see the evidence behind the harmful effects of the staple African American diet and, most importantly, walk away with strategies you can use tomorrow to effect change in this patient population.
This session will explore some of the most relevant questions clinicians have as we approach a year into the COVID-19 pandemic. Faculty will review the cardiovascular complications that are directly and indirectly attributed to COVID-19 that have been documented since the onset of the pandemic as sequelae of fear leading to avoidance of prescription medication use, emergency department avoidance, and missed routine healthcare. This session will explore “long” COVID-19 and long-term cardiovascular manifestations and population-level health implications. Faculty will compare COVID-19 to influenza and explore how to distinguish presentation of these viruses. Lastly, we will focus on preventative measures including the development of a COVID-19 vaccine. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 11/13/2020, and they are subject to change as new information is published.
These troubling times require communication among specialists and primary care. In this COVID-19 ask the expert the faculty will discuss the most pressing and frequently asked questions about this disease and its complications.
The early detection of cancer can significantly improve the treatment and outcomes for patients. Screening is an effective tool for early detection, but emerging evidence constantly shift these recommendations. This case-based presentation will focus on the most recent guidelines from the leading agencies including ACS, NCCN, and USPSTF and discuss strategies on how to apply them to your patients.
As the incidence of diabetes and obesity continue to grow, more Americans will develop serious complications and experience premature mortality from cardiometabolic causes. This session will enable you to stay up to date on recent groundbreaking research and management guideline updates that could change the way you treat your patients with diabetes, obesity, and/or dyslipidemia.
This talk will cover the potential and the challenges in genetic discovery that need to be met in order to support the utility of genomics in clinical care. Genome methods including whole genome sequencing will be covered. The successes in pediatric genetics will be contrasted with the greater challenges in adult medicine.
Improving Patient Outcomes in T2DM: GLP‐1 Receptor Agonists Benefits in Addition to Improved Glucose Control
Over ten percent of the U.S. population suffers disproportionate cardiometabolic risk because of their type 2 diabetes (T2DM). In light of recent data, GLP-1 receptor agonists (GLP-1 RAs) have taken on a more prominent role in T2DM management algorithms. This session will discuss how you can distinguish among GLP-1 RAs and use them in your practice to help manage the risks that these patients face beyond glucose control. A member of the Diabetes Sisters organization will also be joining us to discuss their experience with starting a GLP-1 RA as a patient.
In this virtual, case-based medical education program held during CardiologyNOW 2021, expert faculty will get to the heart of the matter by discussing how to identify patients who are still at risk for cardiovascular events and may benefit from additional treatment despite management of other risk factors.
Participants will review the most updated screening and surveillance guidelines to determine when to start screening their patients for colorectal cancer and when follow up procedures are indicated.